Induction of Apoptosis by Redox-Cycling Quinones

  • Karin Öllinger
  • Katarina Kågedal
Chapter
Part of the Subcellular Biochemistry book series (SCBI, volume 36)

Keywords

Lysosomal Membrane Redox Cycling Protein Adduct Protease Cathepsin Intracellular Redox Balance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aust, S.D., Morehouse, L.A., and Thomas, C.E., 1985, Role of metals in oxygen radical reactions. J. Free Rad. Biol. Med. 1: 3–25CrossRefGoogle Scholar
  2. Agha, A.M. and Gad, M.Z., 1995, Lipid peroxidation and lysosomal integrity in different inflammatory models in rats: the effects of indomethacin and naftazone. Pharmacol. Res. 32: 279–285PubMedCrossRefGoogle Scholar
  3. Baez, S., Segura-Aguilar, J., Widersten, M., Johansson, AS., and Mannervik, B., 1997, Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324: 25–28PubMedGoogle Scholar
  4. Brunk, U.T. and Svensson, I., 1999, Oxidative stress, growth-factor starvation and Fasactivation may all cause apoptosis through lysosomal leak. Redox Report 4: 3–11PubMedCrossRefGoogle Scholar
  5. Brunk, U.T., Dalen, H., Roberg, K.., and Hellquist, H.B., 1997, Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic. Biol. Med. 23: 616–626PubMedCrossRefGoogle Scholar
  6. Buffinton, G.D., Öllinger, K., Brunmark, A., and Cadenas, E., 1989, DT-diaphorase catalyzed reduction of 1,4-naphthoquinone derivatives and glutathione-conjugates. Biochem. J. 257: 561–571PubMedGoogle Scholar
  7. Buttke, T.M. and Sandstrom, P.A., 1994, Oxidative stress as a mediator of apoptosis. Immunol. Today 15: 7–10PubMedCrossRefGoogle Scholar
  8. Capranico, G., Babudri, N., and Casciarri, G., 1986, Lack of effect of glutathione depletion on cytotoxicity, mutagenicity and DNA damage produced by doxorubicin in cultured cells. Chem.-Biol. Interact. 57: 189–201PubMedCrossRefGoogle Scholar
  9. Cataldo, A.M., Hamilton, D.J., Barnett, J.L., Paskevich, P.A., and Nixon, R.A., 1996, Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer’s disease. J. Neurosci. 16: 186–199PubMedGoogle Scholar
  10. Chesis, P.L., Levin, D.E., Smith, M.T., Ernster, L., and Ames, B.N., 1984, Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. USA 81: 1696–1700PubMedCrossRefGoogle Scholar
  11. Cohen, G.M. and ďArcy Doherty, M., 1987, Free radical mediated toxicity by redox cycling chemicals. Br. J. Cancer 55: 46–52Google Scholar
  12. Cummings, J., Willmott, N., Hoey, B.M., Marley, E.S., and Smyth, J.F., 1992, The consequences of doxorubicin quinone reduction in vivo in tumor tissue. Biochem. Pharmacol. 44: 2165–2174PubMedCrossRefGoogle Scholar
  13. Das, T.K. and Mazumdar, S., 2000, Effect of Adriamycin on the boundary lipid structure of cytochrome c oxidase: pico-second time-resolved fluorescence depolarization studies. Biophys. Chem. 86: 15–28PubMedCrossRefGoogle Scholar
  14. Deiss, L.P., Galinka, H., Barissi, H., Cohen, O., and Kimchi, A., 1996, Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-α. EMBO J. 15: 3861–3870PubMedGoogle Scholar
  15. Dekant, W., 1993, Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation. Toxicol. Lett. 67: 151–160PubMedCrossRefGoogle Scholar
  16. Dooley, D.M., 1999, Structure and biogenesis of topaquiones and related cofactors. J. Biol. Inorg. Chem. 4: 1–11PubMedCrossRefGoogle Scholar
  17. Finley, K.T., 1974, The addition and substitution chemistry of quinones. In The chemistry of the quinoid compounds (S. Patai, ed.), John Wiley and Sons, London, pp. 877–1144Google Scholar
  18. Frydman, B., Marton, L.J., Sun, J.S., Neder, K., Witiak, D.T., Liu, A.A., Wang, H.M., Mao, Y., Wu, Y., Sanders, M.M., and Liu, L.F., 1997, Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones. Cancer Res. 57: 620–627PubMedGoogle Scholar
  19. Gewirtz, D. A, 1999, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57: 727–741PubMedCrossRefGoogle Scholar
  20. Guicciardi, M.E., Deussing, J., Miyoshi, H., Bronk, S.F., Svingen, P.A., Peters, C., Kaufmann, S.H. and Gores, G.J., 2000, Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106: 1127–1137PubMedCrossRefGoogle Scholar
  21. Halliwell, B. and Gutteridge, J.M.C., 1999, Free Radicals in Biology and Medicine. Clarendon Press, OxfordGoogle Scholar
  22. Hasinoff, B.B. and Davey, J.P., 1988, Adriamycin and its iron(III) and copper(II) complexes. Biochem. Pharmacol. 37: 3663–3669.PubMedCrossRefGoogle Scholar
  23. Imlay, J.A. and Linn, S., 1988, DNA damage and oxygen radical toxicity. Science 240: 1302–1309PubMedCrossRefGoogle Scholar
  24. Jakoby, W.B. and Ziegler, D.M., 1980, The enzymes of detoxication. J. Biol. Chem. 265: 20715–20718Google Scholar
  25. Kappus, H., 1986, Overview of enzyme systems involved in bioreduction of drugs and in redox cycling. Biochem. Pharmacol. 35: 1–6PubMedCrossRefGoogle Scholar
  26. Kasper, C.B. and Henton, D., 1980, Glucuronidation. In Enzymatic basis of detoxication. (W.B. Jacoby, ed.), Academic Press, New York, pp. 4–36Google Scholar
  27. Kleiner, H.E., Rivera, M.I., Pumfird, N.R., Monks, T.J., and Lau, S.S., 1998, Immunochemical detection of quinol-thioether-derived protein adducts. Chem. Res. Toxicol. 11: 1283–1290PubMedCrossRefGoogle Scholar
  28. Kågedal, K., Bironaite, D., and Öllinger, K., 1999, Anthraquinone cytotoxicity and apoptosis in primary cultures of hepatocytes. Free Rad. Res. 31: 419–428CrossRefGoogle Scholar
  29. Kågedal, K., Johansson, U., and Öllinger, K., 2001, The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J. (May 18, 2001) 10.1096/fj.00-0708fjeGoogle Scholar
  30. Li, W., Yuan, X.M., and Brunk, U.T., 1998, OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radic. Res. 29: 389–398PubMedCrossRefGoogle Scholar
  31. Lin, P.H., Waidyanatha, S., Pollack, G.M., and Rappaport, S.M., 1997, Dosimetry of chlorinated quinone metabolites of pentachlorophenol in the livers of rats and mice based upon measurement of protein adducts. Toxicol. Appl. Pharmacol. 145: 399–408PubMedCrossRefGoogle Scholar
  32. Ling, Y.H., Priebe, W., and Perez-Soler, R., 1993, Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res. 53: 1845–1852PubMedGoogle Scholar
  33. Lothstein, L., Suttle, D.P., Roaten, J.F., Koseki, Y., Israel, M., and Sweatman, T.W., 2000, Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288). Biochem. Pharmacol. 60: 1621–1628PubMedCrossRefGoogle Scholar
  34. Matthews, N., Neale, M.L., Jackson, S.K., and Stark, J.M., 1987, Tumor cell killing by tumor necrosis factor: inhibition by anearobiotic condition, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 62: 153–155PubMedGoogle Scholar
  35. Miller, M.G., Rodgers, A., and Cohen, G.M., 1986, Mechanisms of toxicity of naphthoquinones to isolated hepatocytes. Biochem. Pharmacol. 35: 1177–1184PubMedCrossRefGoogle Scholar
  36. Minko, T., Kopeckova, P., and Kopecek, J., 1999, Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Pharmaceut. Res. 16: 986–996CrossRefGoogle Scholar
  37. Monney, L., Olivier, R., Otter, I., Jansen, B., Poirier, GG., and Borner, C., 1998, Role of an acidic compartment in tumor-necrosis-factor-α-induced production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 251: 295–303PubMedCrossRefGoogle Scholar
  38. Morrison, H., Jernström, B., Nordenskjöld, M., Thor, H., and Orrenius, S., 1984, Induction of DNA damage by menadione (2-methyl-l,4-naphthoquinone) in primary cultures of rat hepatocytes. Biochem. Pharmacol. 33: 1763–1769PubMedCrossRefGoogle Scholar
  39. Neuzil, J., Svensson, I., Weber, T., Weber, C., and Brunk, U.T., 1999, alpha-tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett. 445: 295–300PubMedCrossRefGoogle Scholar
  40. Ngo, E.O., Nutter, L.M., Sura, T., and Gutierrez, P. L., 1998, Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone. Chem. Res. Toxicol. 11: 360–368PubMedCrossRefGoogle Scholar
  41. O’Brien, P.J., 1985, Free-radical-mediated DNA binding. Environ. Health Perspect. 64: 219–232Google Scholar
  42. Öllinger, K., 2000, Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. Arch. Biochem. Biophys, 373: 346–351PubMedCrossRefGoogle Scholar
  43. Öllinger, K. and Brunk, U.T., 1995, Oxidative stress-induced cellular injury is mediated through lysosomal damage. Free Radic. Biol. Med. 19: 565–574PubMedCrossRefGoogle Scholar
  44. Öllinger, K. and Brunmark, A., 1991, Effect of hydroxy substitution on 1,4-naphthoquinone toxicity to rat hepatocytes. J. Biol. Chem. 266: 21496–21503PubMedGoogle Scholar
  45. Öllinger, K. and Brunmark, A., 1994, Effect of different oxygen pressures and DPPD on adriamycin toxicity to cultured neonatal rat heart myocytes. Biochem. Pharmacol. 48: 1707–1715PubMedCrossRefGoogle Scholar
  46. Pan, S., Andrews, P.A., Glover, C.J., and Bachur, N.R., 1984, Reductive activation of mitomycin C and mitomycin C metabolites catalysed by NADPH-cytochorome P-450 reductase and xantine oxidase. J. Biol. Chem. 259: 959–962PubMedGoogle Scholar
  47. Pollakis, G., Goormaghtigh, E., and Ruysschaert, J.-M., 1983, Role of quinone structure in the mitochondrial damage induced by antitumor anthracyclines. FEBS Lett. 155: 267–272PubMedCrossRefGoogle Scholar
  48. Rappaport, S.M., McDonald, T.A., and Yeowell-O’Connell, K., 1996, The use of protein adducts to investigate the disposition of reactive metabolites of benzene. Environ. Health Perspect. 104 Suppl 6: 1235–1237PubMedCrossRefGoogle Scholar
  49. Riley, R.J. and Workman, P., 1992, DT-diaphorase and cancer chemotherapy. Biochem. Pharmacol. 43: 1657–1669PubMedCrossRefGoogle Scholar
  50. Roberg, K., 2001, Relocalization of cathepsin D and cytochrome c early in apoptosis revealed by immunoelectron microscopy. Lab. Invest. 81: 149–158PubMedGoogle Scholar
  51. Roberg, K., Johansson, U., and Öllinger, K., 1999, Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic. Biol. Med. 27: 1228–1237PubMedCrossRefGoogle Scholar
  52. Roberg, K. and Öllinger, K., 1998, Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am. J. Pathol. 152: 1151–1156PubMedGoogle Scholar
  53. Roberts, L.R., Adjei, P.M., and Gores, G.J., 1999, Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem. Biophys. 30: 71–88PubMedCrossRefGoogle Scholar
  54. Robles, S.J., Buehler, P.W., Negrusz, A., and Adami, G.R., 1999, Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camtothecin. Biochem. Pharmacol. 58: 675–685PubMedCrossRefGoogle Scholar
  55. Rossi, L., Moore, G.A., Orrenius, S., and O’Brien, P.J., 1986, Quinone toxicity in hepatocytes without oxidative stress. Arch. Biochem. Biophys. 251: 25–35PubMedCrossRefGoogle Scholar
  56. Serrano, J., Palmeira, C.M., Kuehl, D.W., and Wallace, K.B., 1999, Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim. Biophys. Acta 1411: 201–205PubMedCrossRefGoogle Scholar
  57. Shiah, S.G., Chuang, S.E., Chau, Y.P., Shen, S.C., and Kuo, ML., 1999, Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway. Cancer Res. 59: 391–398PubMedGoogle Scholar
  58. Shibata, M., Kanamori, S., Isahara, K., Ohsawa, Y., Konishi, A., Kametaka, S., Watanabe, T.S., Ishido, K., Kominami, E., and Uchiyama, Y., 1998, Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem. Biophys. Res. Commun. 251: 199–203PubMedCrossRefGoogle Scholar
  59. Skladanowski, A., and Konopa, J., 1993, Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumor cells. Biochem. Pharmacol. 46: 375–382PubMedCrossRefGoogle Scholar
  60. Slater, A.F.G., Nobel, C.S.I., Maelaro, E., Bustamante, J., Kimland, M., and Orrenius, S., 1995, Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway in thymocyte apoptosis. Biochem. J. 306: 771–778PubMedGoogle Scholar
  61. Snyder, R., Jowa, L., Witz, G., Kalf, G., and Rushmore, T., 1987, Formation of reactive metabolites from benzene. Arch. Toxicol. 60: 61–64.PubMedCrossRefGoogle Scholar
  62. Song, G.Y., Zheng, X.G., Kim, Y., Sok, D.E., Ahn, B.Z., 1999, Naphthazarin derivatives (II): formation of glutathione conjugate, inhibition of topoisomerase I and cytotoxicity. Bioorg. Med. Chem. Lett. 9: 2407–2412PubMedCrossRefGoogle Scholar
  63. Stoka, V., Turk, B., Schendel, S.L., Kim, T.-H., Cirman, T., Snipas, S.J., Ellerby, L.M., Bredesen, L., Freeze, H, Abrahamson, M., Brömme, D., Krajewski, S., Reed, J.C., Yin, X.-M., Turk, V., and Salvesen G.S., 2001, Lysosomal Protease Pathways to Apoptosis. Cleavage of Bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276: 3149–3157PubMedCrossRefGoogle Scholar
  64. Sun, X. and Ross, D., 1996, Quinone-induced apoptosis in human colon adenocarcinoma cells via DT-diaphorase mediated bioactivation. Chem. Biol. Interact. 100: 267–76PubMedCrossRefGoogle Scholar
  65. Taatjes, D.J. and Koch, T.H., 2001, Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells. Curr. Med. Chem. 8: 15–29PubMedGoogle Scholar
  66. Tarr, M. and van Helden, P.D., 1990, Inhibition of transcription by adriamycin is a consequence of the loss of negative superhelicity in DNA mediated by topoisomerase II. Mol. Cell Biochem. 93: 141–146PubMedCrossRefGoogle Scholar
  67. Tedone, T., Correale, M., Barbarossa, G., Casavola, V., Paradiso, A., and Reshkin, S.J., 1997, Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion. FASEB J. 11: 785–792PubMedGoogle Scholar
  68. Tilly, J.L. and Tilly, K.I., 1995, Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to supress apoptosis in cultured ovarian follicles. Endocrinology 136: 242–252PubMedCrossRefGoogle Scholar
  69. Thomson, R.H., 1971, Naturally occurring quinones. Academic Press, New YorkGoogle Scholar
  70. Vancompernolle, K., van Herreweghe, F., Pynaert, G., van de Craen, M., De Vos, K., Totty, N., Sterling, A., Fiers, W., Vandenabeele, P., and Grooten, J., 1998, Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett, 438: 150–158PubMedCrossRefGoogle Scholar
  71. Velez-Pardo, C., Jimenez Del Rio, M., Verschueren, H., Ebinger, G., and Vauquelin, G., 1997, Dopamine and iron induce apoptosis in PC12 cells. Pharmacol. Toxicol. 80: 76–84PubMedCrossRefGoogle Scholar
  72. Wu, G.S., Saftig, P., Peters, C., and El-Deiry, W.S., 1998, Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16: 2177–2183PubMedCrossRefGoogle Scholar
  73. Zaleskis, G., Berleth, E., Verstovsek, S., Ehrke, M.J., and Mihich, E., 1994, Doxorubicin-induced DNA degradation in murine thymocytes. Mol. Pharmacol. 46: 901–908PubMedGoogle Scholar
  74. Zeman, S.M., Phillips, D.R., and Crothers, D.M., 1998, Characterization of covalent Adriamycin-DNA adducts. Proc. Natl, Acad. Sci. USA 95: 11561–11565CrossRefGoogle Scholar
  75. Zhang, H., Dahlen H., Öllinger, K., and Brunk, U.T., 1995, Exposure of cells to non lethal concentrations of hydrogen peroxide induces degeneration-repair mechanisms involving lysosomal destabilization. Free Radic. Biol. Med. 19: 813–822PubMedCrossRefGoogle Scholar
  76. Zheng, J., Cho, M., Jones, A.D., and Hammock, B.D., 1997, Evidence of quinone metabolites of naphthalene covalently bound to sulfur nucleophiles of proteins of murine Clara cells after exposure to naphthalene. Chem. Res. Toxicol 10: 1008–1014PubMedCrossRefGoogle Scholar
  77. Zunino, F., Gambetta, R., and Di Marco, A., 1975, The inhibition in vitro of DNA polymerase and RNA polymerases by daunomycin and adriamycin. Biochem. Pharmacol. 24: 309–311CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Karin Öllinger
    • 1
  • Katarina Kågedal
    • 1
  1. 1.Division of Pathology II, Faculty of Health SciencesLinköping UniversityLinköpingSweden

Personalised recommendations